| DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer C Mao, X Liu, Y Zhang, G Lei, Y Yan, H Lee, P Koppula, S Wu, L Zhuang, ... Nature 593 (7860), 586-590, 2021 | 932 | 2021 |
| Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis X Liu, L Nie, Y Zhang, Y Yan, C Wang, M Colic, K Olszewski, A Horbath, ... Nature cell biology 25 (3), 404-414, 2023 | 357 | 2023 |
| A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria S Wu, C Mao, L Kondiparthi, MV Poyurovsky, K Olszewski, B Gan Proceedings of the National Academy of Sciences 119 (26), e2121987119, 2022 | 65 | 2022 |
| RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer K Hui, Y Gao, J Huang, S Xu, B Wang, J Zeng, J Fan, X Wang, Y Yue, ... Cell death & disease 8 (2), e2600-e2600, 2017 | 46 | 2017 |
| SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells Y Yan, H Teng, Q Hang, L Kondiparthi, G Lei, A Horbath, X Liu, C Mao, ... Nature communications 14 (1), 3673, 2023 | 45 | 2023 |
| AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling B Wang, Y Gu, K Hui, J Huang, S Xu, S Wu, L Li, J Fan, X Wang, JT Hsieh, ... Urologic Oncology: Seminars and Original Investigations 36 (10), 472. e11 …, 2018 | 41 | 2018 |
| The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression J Huang, UG Lo, S Wu, B Wang, RC Pong, CH Lai, H Lin, D He, JT Hsieh, ... Cell death & disease 10 (6), 437, 2019 | 28 | 2019 |
| MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma Y Yue, K Hui, S Wu, M Zhang, T Que, Y Gu, X Wang, K Wu, J Fan Cell death & disease 11 (5), 336, 2020 | 25 | 2020 |
| 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling Y Yue, W Qian, J Li, S Wu, M Zhang, Z Wu, Q Ma, Z Wang Cancer Letters 471, 135-146, 2020 | 22 | 2020 |
| The expression and function of RASAL2 in renal cell carcinoma angiogenesis K Hui, Y Yue, S Wu, Y Gu, B Guan, X Wang, JT Hsieh, LS Chang, D He, ... Cell Death & Disease 9 (9), 881, 2018 | 22 | 2018 |
| RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer K Hui, S Wu, Y Yue, Y Gu, B Guan, X Wang, JT Hsieh, LS Chang, D He, ... Cellular signalling 48, 38-44, 2018 | 22 | 2018 |
| Author Correction: DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer C Mao, X Liu, Y Zhang, G Lei, Y Yan, H Lee, P Koppula, S Wu, L Zhuang, ... Nature 596 (7873), E13-E13, 2021 | 17 | 2021 |
| The AKR1C3/AR‐V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression B Wang, S Wu, Y Fang, G Sun, D He, JT Hsieh, X Wang, H Zeng, K Wu Journal of cellular and molecular medicine 24 (20), 12032-12043, 2020 | 17 | 2020 |
| 2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer S Wu, J Huang, K Hui, Y Yue, Y Gu, Z Ning, X Wang, D He, K Wu Oncology Reports 40 (5), 2836-2843, 2018 | 14 | 2018 |
| MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3β/β-catenin signaling S Wu, Y Yue, Y Gu, Q Wang, T Liu, L Li, X Wang, LS Chang, D He, K Wu Cellular Signalling 84, 110015, 2021 | 11 | 2021 |
| RASAL2 regulates the cell cycle and cyclin D1 expression through PI3K/AKT signalling in prostate tumorigenesis Q Wang, S Wu, Y Gu, H Liang, F He, X Wang, D He, K Wu Cell Death Discovery 8 (1), 275, 2022 | 6 | 2022 |
| DAB2IP regulates intratumoral testosterone synthesis and CRPC tumor growth by ETS1/AKR1C3 signaling Y Gu, S Wu, Y Chong, B Guan, L Li, D He, X Wang, B Wang, K Wu Cellular Signalling 95, 110336, 2022 | 4 | 2022 |
| DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer., 2021, 593 C Mao, X Liu, Y Zhang, G Lei, Y Yan, H Lee, P Koppula, S Wu, L Zhuang, ... DOI: https://doi. org/10.1038/s41586-021-03539-7, 586-590, 2021 | 4 | 2021 |
| DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer (vol 593, pg 586, 2021) C Mao, X Liu, Y Zhang, G Lei, Y Yan, H Lee, P Koppula, S Wu, L Zhuang, ... Nature 596 (7873), E13-E13, 2021 | | 2021 |
| 上尿路尿路上皮癌肾积水与相关临床特征的关系 岳阳阳， 惠珂， 武士琪， 阙滔滔， 裴昕奇， 贺大林， 吴大鹏， 范晋海， 吴开杰 现代泌尿外科杂志 22 (7), 510-512, 2017 | | 2017 |
